We are live on
!
Find out more
AFM
Abbot Financial Management Portfolio holdings
AUM
$239M
1-Year Est. Return
27.19%
This Fund
S&P 500
This Quarter
Est. Return
+3.1%
1 Year Est. Return
+27.19%
3 Year Est. Return
+80.47%
5 Year Est. Return
+79.47%
10 Year Est. Return
–
AUM
$201M
AUM Growth
+$2.15M
(+1.1%)
Cap. Flow
-$1.34M
Cap. Flow
% of AUM
-0.67%
Top 10 Holdings %
Top 10 Hldgs %
39.25%
Holding
129
New
2
Increased
40
Reduced
45
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$511K |
| 2 |
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
|
+$341K |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$334K |
| 4 |
Fidelity Total Bond ETF
FBND
|
+$234K |
| 5 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$189K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Celanese
CE
|
+$979K |
| 2 |
Intel
INTC
|
+$746K |
| 3 |
Pfizer
PFE
|
+$297K |
| 4 |
Diageo
DEO
|
+$270K |
| 5 |
Eli Lilly
LLY
|
+$202K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.65% |
| 2 | Financials | 12.83% |
| 3 | Healthcare | 7.58% |
| 4 | Industrials | 7.26% |
| 5 | Consumer Discretionary | 6.36% |
Similar funds
NEPPG
HC
CWM
SP
I2I
IIM
MMM
M
Abbot Financial Management's Q4 2024 Portfolio in Review
As of Q4 2024, Abbot Financial Management held 129 positions worth $201M, up 1.1% from $199M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Abbot Financial Management's Q4 2024 filing shows 2 new, 40 increased, 45 reduced and 5 closed positions. Its largest new stake was Broadcom: 2,764 shares worth $641K. The largest sale was Celanese, an estimated $979K.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Abbot Financial Management's largest Q4 2024 buy was Broadcom: 2,764 shares worth $641K.
- Abbot Financial Management added most to First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF in Q4 2024, an estimated $341K increase.
- Abbot Financial Management's biggest Q4 2024 reduction was Pfizer, cutting an estimated $297K.
- Abbot Financial Management fully exited Celanese in Q4 2024, selling an estimated $979K.
- Abbot Financial Management's ten largest holdings make up 39% of its $201M portfolio in Q4 2024.
- Abbot Financial Management opened 2 new positions and closed 5 in Q4 2024.
- Abbot Financial Management's portfolio value rose 1.1% quarter-over-quarter to $201M.
Based on Abbot Financial Management's 13F filing for Q4 2024, filed 6 Feb 2025.